MetaCap

Grifols S.A. (GRFS) News

NASDAQ: GRFSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

8.15-0.05 (-0.61%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

GRFS news summary

We found 4 recent headlines mentioning Grifols S.A. (GRFS): 0 in the past week and 3 in the past 30 days, most often from Nasdaq. For price context, GRFS is down 0.61% at $8.15. The most recent story, "ADMA Surges 20.9% Post Q3 Earnings: Buy, Sell or Hold the Stock?", was published by Nasdaq on Nov 11, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Grifols S.A. headlines

Stocks mentioned alongside GRFS

Compare GRFS